Market closed
Biodesix/$BDSX
14:30
16:10
17:45
19:25
21:00
1D1W1MYTD1Y5YMAX
About Biodesix
Biodesix Inc is a diagnostic solutions company with a focus in lung disease. The Company has a single operating segment focused on providing diagnostic testing services to customers. It provides biopharmaceutical companies with services that include diagnostic research, clinical trial testing, and the discovery, development, and commercialization of companion diagnostics. The revenue is derived from two sources, providing diagnostic testing services associated with blood-based lung and Coronavirus Disease 2019 (COVID-19) tests; and providing biopharmaceutical companies with services generally provided outside the clinical setting and governed by individual contracts with third parties as well as development and commercialization of companion diagnostics.
Ticker
$BDSX
Sector
Trading on
Industry
Health Care Providers & Services
Headquarters
Employees
217
Website
Biodesix Metrics
BasicAdvanced
$198M
Market cap
-
P/E ratio
-$0.38
EPS
1.21
Beta
-
Dividend rate
Price and volume
Market cap
$198M
Beta
1.21
52-week high
$2.21
52-week low
$1.11
Average daily volume
580K
Financial strength
Current ratio
3.396
Quick ratio
3.043
Long term debt to equity
220.063
Total debt to equity
224.36
Interest coverage (TTM)
-3.91%
Management effectiveness
Return on assets (TTM)
-22.79%
Return on equity (TTM)
-331.82%
Valuation
Price to revenue (TTM)
2.403
Price to book
7.1
Price to tangible book (TTM)
30.97
Price to free cash flow (TTM)
-2.525
Growth
Revenue change (TTM)
48.92%
Earnings per share change (TTM)
-56.17%
3-year revenue growth (CAGR)
-4.09%
3-year earnings per share growth (CAGR)
-34.78%
What the Analysts think about Biodesix
Analyst Ratings
Analyst ratings (Buy, Hold, Sell) for Biodesix stock.
Biodesix Financial Performance
Income Statement
Revenues and expenses
QuarterlyAnnual
Q3 24
QoQ growth
Revenue
$37B
-39.75%
Net income
$45B
107.52%
Profit margin
37.65%
6.78%
Biodesix Earnings Performance
Earnings per share (EPS)
Company profitability
QuarterlyAnnual
Q4 23
Q1 24
Q2 24
Q3 24
Q4 24
Actual
$3.69
$2.85
$2.45
$2.42
-
Expected
$3.55
$2.61
$2.05
$2.31
$3.94
Surprise
3.94%
9.20%
19.51%
4.63%
-
Biodesix News
AllArticlesVideos
Data displayed above is indicative only and its accuracy or completeness is not guaranteed. Actual execution price may vary. Past performance is not indicative of future results. Your return may be affected by currency fluctuations and applicable fees and charges. Capital at risk.
Real time US market data is a consolidated feed of IEX, NYSE National, NYSE Chicago, Nasdaq BX and Nasdaq PSX order books provided by Polygon. After-hours US market data is 15 minutes delayed and may differ significantly from the actual tradable price at market open.
FAQs
What’s the current market cap for Biodesix stock?
Biodesix (BDSX) has a market cap of $198M as of December 21, 2024.
What is the P/E ratio for Biodesix stock?
The price to earnings (P/E) ratio for Biodesix (BDSX) stock is 0 as of December 21, 2024.
Does Biodesix stock pay dividends?
No, Biodesix (BDSX) stock does not pay dividends to its shareholders as of December 21, 2024.
When is the next Biodesix dividend payment date?
Biodesix (BDSX) stock does not pay dividends to its shareholders.
What is the beta indicator for Biodesix?
Biodesix (BDSX) has a beta rating of 1.21. This means that it is more volatile than the market, on average. A beta of 1 would indicate the stock moves in-line with the market, while a beta of 2 would indicate the stock moves twice as much as the market.